Aptiva acquisition expands patient base, strengthens leadership in CGM market
By HME News Staff
Updated 10:30 AM CDT, Wed October 8, 2025
FORT LAUDERDALE, Fla. – Aptiva Medical, a provider of continuous glucose monitoring (CGM) systems and a portfolio company of Greenleaf Ventures, has completed its acquisition of VeraMed Health.
The company says the transaction significantly expands its patient base, strengthens its referral and payer networks, and accelerates its rapid growth – further reinforcing its leadership in delivering advanced diabetes management solutions to patients across the country.
"This acquisition aligns perfectly with Aptiva Medical's mission to build a leading, nationwide direct-to-patient CGM business," said David Wallace, co-founder and managing partner of Greenleaf Ventures. "The VeraMed team has built an excellent foundation of patient care, and Aptiva Medical will ensure a seamless transition for every patient while continuing to raise the bar on service and efficiency."
Wallace and Timothy Stocksdale, co-founder of Greenleaf Ventures, have a long track record of building and scaling successful health care companies in the medical supply and pharmacy sectors, including Access Diabetic Supply, Arriva Medical, Comfort Medical, and AmerimedRx. In 2014, they acquired Liberty Medical out of bankruptcy and restructured it, later selling it to Cardinal Health.
Comments